Atlas Trials

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

Clinical trial NCT01460186 · COMPLETED

Trial details

NCT number
NCT01460186
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerMetastasis
Start date
2011-12-01
Primary completion
2017-09-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.